Women's Fem Dophilus®

Suggested/Recommended/Usage/Directions

Usage: For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional.

Suggested/Recommended/Usage/Directions

USAGE: For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.

Storage

NO REFRIGERATION NECESSARY

Storage

Fem-Dophilus does not require refrigeration and can be stored at room temperature. Refrigeration will, however, extend the shelf life. Avoid temperatures above 77(0)F (25(0)C).

Storage

Minimum 1 Billion viable cells per capsule when within Best Used Before Date.

Formulation re: Vegetarian/Vegan

Suitable for Vegetarians/Vegans

Formulation re: Does NOT Contain

Non-GMO ~ Free of Major Allergens

Formula re: Type

VAGINAL/URINARY TRACT HEALTH*

Formulation re: Does NOT Contain

No wheat, no gluten, no soybeans, no dairy, no egg, no fish/shellfish, no peanuts/tree nuts.

Formula re: Contains

Fem-Dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1 and Lactobacillus reuteri, RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech.

FDA Disclaimer Statement

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

FDA Statement of Identity

ORAL PROBIOTIC SUPPLEMENT

Brand IP Statement(s) re: (c), (TM), (SM)

Under license from Chr. Hansen A/S and protected by Chr. Hansen A/S patents of the WO 00/35465 patent family, and others.

Brand IP Statement(s) re: (c), (TM), (SM)

2015 Jarrow Formulas

General Statements: All Other Content

Made in Denmark by Chr. Hansen A/S

Seals/Symbols

Gluten Free

Seals/Symbols

Vegan V

Seals/Symbols

Veggie Caps

Seals/Symbols

NON GENETICALLY MODIFIED NON GMO

Brand IP Statement(s) re: (c), (TM), (SM)

Superior Nutrition and Formulation

Brand IP Statement(s) re: (c), (TM), (SM)

GR-1/RC-14 and VAGINAL FLORA (also called microbiota)

Brand IP Statement(s) re: (c), (TM), (SM)

In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.

Brand IP Statement(s) re: (c), (TM), (SM)

{chart} GR-1/ RC-14 75% Control Group 34%

General Statements: All Other Content

Martinez, et al. Can J Microbiol 2009;55:133-138

Brand IP Statement(s) re: (c), (TM), (SM)

{chart} 25+ YEARS OF GR-1/ RC-14 RESEARCH / CLINICAL STUDIES First Research on GR-1/RC-14 Strains Begin 27 Clinical Studies Published Between 2001 and 2014 Fem-Dophilus Introduced (2006)

Brand IP Statement(s) re: (c), (TM), (SM)

Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.*

General Statements: All Other Content

25+ years of research/clinical studies**

General Statements: All Other Content

New Shelf Stable

Brand IP Statement(s) re: (c), (TM), (SM)

RC-14 and GR-1 are registered trademarks of Chr. Hansen A/S.

General: Product/Version Code

04515FEMS PROD # 103041